Gencove Closes $10 Million in Series A  

by Kay Aloha Villamor in November 1st, 2021

Gencove, a New York-based leading low-pass genome sequencing platform company, closed $10 million in Series A investment bringing the company's total financing to $16.2 million. 

The round was led by Lewis & Clark AgriFood, with participation from new and existing investors including Spero Ventures, Techammer, Third Kind Venture Capital, and Version One Ventures. 

Funding will be used for further product development, commercial growth and to build out key business functions. 

Company: Gencove, Inc

Raised: $10.0M

Round: Series A

Funding Month: October 2021

Lead Investors: Lewis & Clark AgriFood

Additional Investors: Spero Ventures, Techammer, Third Kind Venture Capital, and Version One Ventures

Company Website:

Software Category: Genome sequencing platform

About the Company: Gencove is democratizing genome sequencing by making genomic information more accessible and interpretable through the development of molecular and computational tools. Gencove's low-pass sequencing platform is setting a new standard for high-throughput, cost-effective genomics research across species. The company operates a laboratory in New York and offers both low-pass sequencing and analytics software as a service. Together with academic, agriculture, biotechnology, and pharmaceutical companies, Gencove is dedicated to solving the world's most pressing challenges. In addition to Gencove's low-pass whole genome sequencing and SAAS platform, the company has developed large cross-species genomic datasets and reference panels. 



Your cart